<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336444">
  <stage>Registered</stage>
  <submitdate>21/01/2011</submitdate>
  <approvaldate>10/02/2011</approvaldate>
  <actrnumber>ACTRN12611000160932</actrnumber>
  <trial_identification>
    <studytitle>Quality of life, days in hospital, lung function and fitness before and after attending the outpatient cystic fibrosis (CF) physiotherapy service</studytitle>
    <scientifictitle>Children and adolescents with cystic fibrosis attending the Women's and Children's Hospital Ambulatory Cystic Fibrosis Physiotherapy Clinic - effect on quality of life, number of occupied bed days, pulmonary function and exercise capacity.</scientifictitle>
    <utrn>U1111-1119-1890</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cystic fibrosis</healthcondition>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects will attend up to 52 (depending on need and assessed on a case by case basis) 1-1.5 hour weekly outpatient appointments with a physiotherapist who will work with the patient and family to optimise and individualise the patients airway clearance techniques including positive expiratory pressure, inhalation techinques, postural drainage, and autogenic drainage. During the outpatient sessions, patients will participate in physical activity including aerobic and anaerobic activities.  Principles of chronic condition self management will be engaged to increase patient participation and treatment adherence.</interventions>
    <comparator>Before and after baseline data for each patient will be used ie 2010 compared to 2011</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Lifestyle</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of admissions and occupied bed days.  Information generated by the Women's and Children's Hospital HIPPO (Health Informatics, Performance, Planning and Outcomes) Unit</outcome>
      <timepoint>Number of admssions and occupied bed days in 2010 and 2011</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life score using the CFQ-R (Cystic Fibrosis Questionnaire - Revised</outcome>
      <timepoint>At commencement of clinic participation (January 2010) and at the end of 2011 (Decemeber 2011)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Pulmonary function, best FVC, FEV1 and MMEF using standard spirometry.</outcome>
      <timepoint>Best for 2010 and 2011</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Exercise capacity determined by distance travelled on the modified shuttle walk test and VO2max</outcome>
      <timepoint>At commencement of clinic participation (January 2010) and at the end of 2011 (Decemeber 2011)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with cystic fibrosis who have had 3 or more respiratory related admissions to the Women's and Children's Hospital in 2010/2011.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients who do not consent to participating in the Ambulatory CF Physiotherapy clinic</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>5/01/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>14</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Angela Potter</primarysponsorname>
    <primarysponsoraddress>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>GP Plus</fundingname>
      <fundingaddress>c/o SA Health
PO Box 287 Rundle Mall 
Adelaide SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Phil Calvert</sponsorname>
      <sponsoraddress>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Jodie-Ann Hochuli</othercollaboratorname>
      <othercollaboratoraddress>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the effect of participation in the new Ambulatory CF Physiotherapy Clinic on patients' quality of life, lung function, fitness and number of days in hospital.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Children, Youth and Women's Health Service Human Research Ethics Committee</ethicname>
      <ethicaddress>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</ethicaddress>
      <ethicapprovaldate>17/12/2010</ethicapprovaldate>
      <hrec>REC2342/12/13</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Angela Potter</name>
      <address>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</address>
      <phone>61 8 8161 7381</phone>
      <fax>61 8 8161 7040</fax>
      <email>angela.potter@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Angela Potter</name>
      <address>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</address>
      <phone>61 8 8161 7381</phone>
      <fax>61 8 8161 7040</fax>
      <email>angela.potter@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Angela Potter</name>
      <address>Women's and Children's Hospital
72 King William St
North Adelaide 5006
South Australia</address>
      <phone>61 8 8161 7381</phone>
      <fax>61 8 8161 7040</fax>
      <email>angela.potter@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>